2Pauwels RA,Buist AS,Calverley PM,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease.NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.Am J Respir Crit Care Med,2001,163(5):1256-1276.
4Jaffuel D,Demoly P,Gougat C,et al.Am J Respir Crit Care Med,2000,162(1):57-63.
5Calverley PMA,Pauwels RA,Vestbo J,et al.Salmeterol/fluticasone propionate combination for one year provides greater clinical benefit than its individual components in COPD.Am J Respir Crit Care Med,2002,165(8):A226.
6Vestbo J,Pauwels RA,Calverley PMA,et al.Salmeterol/fluticasone propionate combination produces improvement in lung function detectable within 24 hours in moderate to severe COPD.Am J Rspir Crit Care Med,2003,167(7):A89.
7Hanania NA,Darken P,Horstman D.The efficacy and safety of fluticasone propionate(250microg)/salmeterol(50microg) combined in the Diskus inhaler for the treatment of COPD.Chest,2003,124(3):834-843.
8Cazzola M,Di Lorenzo G,Di Perna F.Additive effects of salmeterol and fluticasone or theophylline in COPD.Chest,2000,118(6):1576-1581.
9Pauwels RA,Vestbo J,Calverley PMA,et al.Characterisation of exacerbations in the TRISTAN study of salmeterol/fluticasone propionate combination in moderate to severe COPD.Am J Respir Crit Care Med,2003,167(7):A949.
10Pauwels RA,Vestbo J,Calverley PMA,et al.Reduction of exacerbations with salmeterol/fluticasone combination 50/500mcg bd in the treatment of COPD.Eur Respir J,2002,20(Suppl 38):241s.
